speb/financial-data huggingface dataset:
CRVO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 11500000.00
CRVO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2326326.00
CRVO balance_sheet (quarterly, 2025-09-30) — Share Issued: 9252719.00
CRVO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 291717.00
CRVO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 26011464.00
CRVO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 26011464.00
CRVO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Assets: 30610778.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 26011464.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 26011464.00
CRVO income_statement (quarterly, 2025-09-30) — Total Expenses: 8044199.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4599314.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -8044199.00
CRVO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 30456.00
CRVO balance_sheet (quarterly, 2025-09-30) — Working Capital: 26011464.00
CRVO income_statement (annual, 2025-12-31) — +Operating Expense: 28294877.00
CRVO income_statement (quarterly, 2025-12-31) — +Operating Expense: 8331519.00
CRVO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CRVO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Accounts Payable: 1454118.00
CRVO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1454118.00
CRVO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 115905684.00
CRVO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 115905684.00
CRVO cash_flow (annual, 2025-12-31) — Amortization Of Securities: -854077.00
CRVO cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -146058.00
CRVO income_statement (annual, 2025-12-31) — Basic Average Shares: 9041760.00
CRVO income_statement (annual, 2025-12-31) — Basic EPS: -2.98
CRVO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8999496.00
CRVO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9437400.00
CRVO balance_sheet (annual, 2025-12-31) — Capital Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 9252.00
CRVO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8235469.00
CRVO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8235469.00
CRVO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 20864439.00
CRVO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 20864439.00
CRVO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 4588687.00
CRVO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CRVO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 18097249.00
CRVO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 5373768.00
CRVO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -23449963.00
CRVO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6575699.00
CRVO cash_flow (annual, 2025-12-31) — Change In Account Payable: -67322.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 94899.00
CRVO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 834157.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -48096.00
CRVO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -310581.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -41250.00
CRVO cash_flow (annual, 2025-12-31) — Change In Payable: -67322.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Payable: 94899.00
CRVO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 766835.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 46803.00
CRVO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 638355.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 418967.00
CRVO cash_flow (annual, 2025-12-31) — Change In Receivables: 1827238.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 934394.00
CRVO cash_flow (annual, 2025-12-31) — Change In Working Capital: 2921847.00
CRVO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1358914.00
CRVO cash_flow (annual, 2025-12-31) — Changes In Cash: -764027.00
CRVO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1201931.00
CRVO balance_sheet (annual, 2025-12-31) — Common Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-12-31) — Common Stock: 9252.00
CRVO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 18222901.00
CRVO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 4588687.00
CRVO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2016394.00
CRVO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2016394.00
CRVO balance_sheet (annual, 2025-12-31) — Current Assets: 22879018.00
CRVO balance_sheet (quarterly, 2025-12-31) — Current Assets: 22879018.00
CRVO balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 320581.00
CRVO balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 320581.00
CRVO balance_sheet (annual, 2025-12-31) — Current Liabilities: 4656117.00
CRVO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4656117.00
CRVO income_statement (annual, 2025-12-31) — Diluted Average Shares: 9041760.00
CRVO income_statement (annual, 2025-12-31) — Diluted EPS: -2.98
CRVO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8087290.00
CRVO income_statement (annual, 2025-12-31) — EBIT: -28294877.00
CRVO income_statement (quarterly, 2025-12-31) — EBIT: -8331519.00
CRVO income_statement (annual, 2025-12-31) — EBITDA: -28294877.00
CRVO income_statement (quarterly, 2025-12-31) — EBITDA: -8331519.00
CRVO cash_flow (annual, 2025-12-31) — End Cash Position: 8235469.00
CRVO cash_flow (quarterly, 2025-12-31) — End Cash Position: 8235469.00
CRVO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 4588687.00
CRVO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
CRVO cash_flow (annual, 2025-12-31) — Free Cash Flow: -23449963.00
CRVO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -6575699.00
CRVO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5816.00
CRVO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5816.00
CRVO income_statement (annual, 2025-12-31) — General And Administrative Expense: 10484315.00
CRVO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2510038.00
CRVO income_statement (annual, 2025-12-31) — Interest Income: 1336837.00
CRVO income_statement (quarterly, 2025-12-31) — Interest Income: 240938.00
CRVO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1336837.00
CRVO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 240938.00
CRVO balance_sheet (annual, 2025-12-31) — Invested Capital: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 18222901.00
CRVO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 18097249.00
CRVO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 5373768.00
CRVO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 4588687.00
CRVO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CRVO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 4588687.00
CRVO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CRVO income_statement (annual, 2025-12-31) — Net Income: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8087290.00
CRVO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -26966367.00
CRVO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8087290.00
CRVO income_statement (annual, 2025-12-31) — Net Interest Income: 1336837.00
CRVO income_statement (quarterly, 2025-12-31) — Net Interest Income: 240938.00
CRVO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 18097249.00
CRVO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 5373768.00
CRVO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1336837.00
CRVO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 240938.00
CRVO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 18222901.00
CRVO income_statement (annual, 2025-12-31) — Normalized EBITDA: -28294877.00
CRVO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -8331519.00
CRVO income_statement (annual, 2025-12-31) — Normalized Income: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Normalized Income: -8087290.00
CRVO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -23449963.00
CRVO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -6575699.00
CRVO income_statement (annual, 2025-12-31) — Operating Income: -28294877.00
CRVO income_statement (quarterly, 2025-12-31) — Operating Income: -8331519.00
CRVO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
CRVO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 9252719.00
CRVO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 9252719.00
CRVO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 83383.00
CRVO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 83383.00
CRVO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 5816.00
CRVO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 5816.00
CRVO income_statement (annual, 2025-12-31) — Other Gand A: 10484315.00
CRVO income_statement (quarterly, 2025-12-31) — Other Gand A: 2510038.00
CRVO income_statement (annual, 2025-12-31) — Other Income Expense: -8327.00
CRVO income_statement (quarterly, 2025-12-31) — Other Income Expense: 3291.00
CRVO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -8327.00
CRVO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3291.00
CRVO income_statement (annual, 2025-12-31) — Other Operating Expenses: -4006510.00
CRVO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -8726.00
CRVO balance_sheet (annual, 2025-12-31) — Other Receivables: 426993.00
CRVO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 426993.00
CRVO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 12628970.00
CRVO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 12628970.00
CRVO balance_sheet (annual, 2025-12-31) — Payables: 1494574.00
CRVO balance_sheet (quarterly, 2025-12-31) — Payables: 1494574.00
CRVO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3510968.00
CRVO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3510968.00
CRVO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1061766.00
CRVO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1061766.00
CRVO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRVO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1267005.00
CRVO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1267005.00
CRVO income_statement (annual, 2025-12-31) — Pretax Income: -26966367.00
CRVO income_statement (quarterly, 2025-12-31) — Pretax Income: -8087290.00
CRVO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -25402751.00
CRVO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -4626232.00
CRVO balance_sheet (annual, 2025-12-31) — Receivables: 426993.00
CRVO balance_sheet (quarterly, 2025-12-31) — Receivables: 426993.00
CRVO income_statement (annual, 2025-12-31) — Research And Development: 21817072.00
CRVO income_statement (quarterly, 2025-12-31) — Research And Development: 5830207.00
CRVO balance_sheet (annual, 2025-12-31) — Retained Earnings: -97697851.00
CRVO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -97697851.00
CRVO cash_flow (annual, 2025-12-31) — Sale Of Investment: 43500000.00
CRVO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 10000000.00
CRVO income_statement (annual, 2025-12-31) — Selling General And Administration: 10484315.00
CRVO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2510038.00
CRVO balance_sheet (annual, 2025-12-31) — Share Issued: 9252719.00
CRVO balance_sheet (quarterly, 2025-12-31) — Share Issued: 9252719.00
CRVO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1448634.00
CRVO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 298735.00
CRVO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 18222901.00
CRVO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 18222901.00
CRVO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CRVO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Total Assets: 22879018.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Assets: 22879018.00
CRVO balance_sheet (annual, 2025-12-31) — Total Capitalization: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 18222901.00
CRVO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 18222901.00
CRVO income_statement (annual, 2025-12-31) — Total Expenses: 28294877.00
CRVO income_statement (quarterly, 2025-12-31) — Total Expenses: 8331519.00
CRVO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 4656117.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4656117.00
CRVO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -28294877.00
CRVO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -8331519.00
CRVO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 40456.00
CRVO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 40456.00
CRVO balance_sheet (annual, 2025-12-31) — Working Capital: 18222901.00
CRVO balance_sheet (quarterly, 2025-12-31) — Working Capital: 18222901.00
CRVO income_statement (quarterly, 2026-03-31) — +Operating Expense: 8110524.00
CRVO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CRVO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2272497.00
CRVO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 116268674.00
CRVO cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -70104.00
CRVO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 9258319.00
CRVO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.86
CRVO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8235469.00
CRVO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 9258.00
CRVO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7941751.00
CRVO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 12923981.00
CRVO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 13800.00
CRVO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 7710820.00
CRVO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -8018338.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 765364.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1097293.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Payable: 765364.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -331929.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -428336.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 426993.00
CRVO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -333272.00
CRVO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -293718.00
CRVO balance_sheet (quarterly, 2026-03-31) — Common Stock: 9258.00
CRVO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10615715.00
CRVO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1634491.00
CRVO balance_sheet (quarterly, 2026-03-31) — Current Assets: 15112918.00
CRVO balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 493596.00
CRVO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 4497203.00
CRVO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 9258319.00
CRVO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.86
CRVO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — EBIT: -8110524.00
CRVO income_statement (quarterly, 2026-03-31) — EBITDA: -8110524.00
CRVO cash_flow (quarterly, 2026-03-31) — End Cash Position: 7941751.00
CRVO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 13800.00
CRVO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -8018338.00
CRVO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -208.00
CRVO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2975105.00
CRVO income_statement (quarterly, 2026-03-31) — Insurance And Claims: 214764.00
CRVO income_statement (quarterly, 2026-03-31) — Interest Income: 147387.00
CRVO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 147387.00
CRVO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10615715.00
CRVO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 7710820.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -7964158.00
CRVO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -7964158.00
CRVO income_statement (quarterly, 2026-03-31) — Net Interest Income: 147387.00
CRVO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 7710820.00
CRVO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 147387.00
CRVO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 10615715.00
CRVO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -8110524.00
CRVO income_statement (quarterly, 2026-03-31) — Normalized Income: -7964158.00
CRVO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -8018338.00
CRVO income_statement (quarterly, 2026-03-31) — Operating Income: -8110524.00
CRVO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CRVO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 9258719.00
CRVO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 83337.00
CRVO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -208.00
CRVO income_statement (quarterly, 2026-03-31) — Other Gand A: 1221425.00
CRVO income_statement (quarterly, 2026-03-31) — Other Income Expense: -1021.00
CRVO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1021.00
CRVO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4982230.00
CRVO balance_sheet (quarterly, 2026-03-31) — Payables: 2322953.00
CRVO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3957444.00
CRVO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 456422.00
CRVO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CRVO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1695341.00
CRVO income_statement (quarterly, 2026-03-31) — Pretax Income: -7964158.00
CRVO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 13800.00
CRVO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -989180.00
CRVO balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
CRVO income_statement (quarterly, 2026-03-31) — Research And Development: 5135419.00
CRVO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -105662009.00
CRVO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1538916.00
CRVO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 8700000.00
CRVO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2975105.00
CRVO balance_sheet (quarterly, 2026-03-31) — Share Issued: 9258719.00
CRVO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 349196.00
CRVO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10615715.00
CRVO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 10615715.00
CRVO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Assets: 15112918.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10615715.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10615715.00
CRVO income_statement (quarterly, 2026-03-31) — Total Expenses: 8110524.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4497203.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -8110524.00
CRVO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 50456.00
CRVO balance_sheet (quarterly, 2026-03-31) — Working Capital: 10615715.00
CRVS income_statement (annual, 2021-12-31) — Basic Average Shares: 41854110.00
CRVS income_statement (annual, 2021-12-31) — Basic EPS: -1.03
CRVS balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 3190000.00
CRVS cash_flow (annual, 2021-12-31) — Capital Expenditure: -5000.00
CRVS income_statement (annual, 2021-12-31) — Diluted Average Shares: 41854110.00
CRVS income_statement (annual, 2021-12-31) — Diluted EPS: -1.03
CRVS balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 507000.00
CRVS cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
CRVS income_statement (annual, 2021-12-31) — Interest Expense: 15000.00
CRVS income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 15000.00
CRVS income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 235000.00
CRVS income_statement (annual, 2021-12-31) — Total Other Finance Cost: 15000.00
CRVS income_statement (annual, 2022-12-31) — +Operating Expense: 32565000.00
CRVS income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Accounts Payable: 1976000.00
CRVS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 588000.00
CRVS balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 45000.00
CRVS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -4546000.00
CRVS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 364361000.00
CRVS cash_flow (annual, 2022-12-31) — Amortization Of Securities: -170000.00
CRVS income_statement (annual, 2022-12-31) — Basic Average Shares: 46553511.00
CRVS income_statement (annual, 2022-12-31) — Basic EPS: -0.89
CRVS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 63458000.00
CRVS cash_flow (annual, 2022-12-31) — Capital Expenditure: -269000.00
CRVS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2601000.00
CRVS balance_sheet (annual, 2022-12-31) — Capital Stock: 5000.00
CRVS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 13159000.00
CRVS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 42303000.00
CRVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CRVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -23276000.00
CRVS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -27023000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Account Payable: 411000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 467000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 1080000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1046000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Payable: 411000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 878000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 581000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Receivables: -81000.00
CRVS cash_flow (annual, 2022-12-31) — Change In Working Capital: 1412000.00
CRVS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -81000.00
CRVS cash_flow (annual, 2022-12-31) — Changes In Cash: -50299000.00
CRVS balance_sheet (annual, 2022-12-31) — Common Stock: 5000.00
CRVS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 56115000.00
CRVS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6277000.00
CRVS balance_sheet (annual, 2022-12-31) — Current Assets: 43664000.00
CRVS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1228000.00
CRVS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1228000.00
CRVS balance_sheet (annual, 2022-12-31) — Current Liabilities: 10752000.00
CRVS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 367000.00
CRVS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 367000.00
CRVS income_statement (annual, 2022-12-31) — Diluted Average Shares: 46553511.00
CRVS income_statement (annual, 2022-12-31) — Diluted EPS: -0.89
CRVS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -41307000.00
CRVS balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 588000.00
CRVS income_statement (annual, 2022-12-31) — EBIT: -32565000.00
CRVS income_statement (annual, 2022-12-31) — EBITDA: -32198000.00
CRVS income_statement (annual, 2022-12-31) — Earnings From Equity Interest: -10005000.00
CRVS cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 10005000.00
CRVS cash_flow (annual, 2022-12-31) — End Cash Position: 13159000.00
CRVS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
CRVS cash_flow (annual, 2022-12-31) — Free Cash Flow: -27292000.00
CRVS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CRVS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -22000.00
CRVS income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 22000.00
CRVS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -563000.00
CRVS income_statement (annual, 2022-12-31) — General And Administrative Expense: 8097000.00
CRVS balance_sheet (annual, 2022-12-31) — Gross PPE: 7116000.00
CRVS income_statement (annual, 2022-12-31) — Interest Income: 654000.00
CRVS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 654000.00
CRVS balance_sheet (annual, 2022-12-31) — Invested Capital: 56115000.00
CRVS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -23276000.00
CRVS balance_sheet (annual, 2022-12-31) — Investments And Advances: 21877000.00
CRVS balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 21877000.00
CRVS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Leases: 2084000.00
CRVS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 1373000.00
CRVS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1373000.00
CRVS balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 21877000.00
CRVS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 142000.00
CRVS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CRVS income_statement (annual, 2022-12-31) — Net Income: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -41307000.00
CRVS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -41307000.00
CRVS income_statement (annual, 2022-12-31) — Net Interest Income: 654000.00
CRVS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -23029000.00
CRVS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 654000.00
CRVS balance_sheet (annual, 2022-12-31) — Net PPE: 2570000.00
CRVS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -247000.00
CRVS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 56115000.00
CRVS income_statement (annual, 2022-12-31) — Normalized EBITDA: -32220000.00
CRVS income_statement (annual, 2022-12-31) — Normalized Income: -41329000.00
CRVS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -27023000.00
CRVS cash_flow (annual, 2022-12-31) — Operating Gains Losses: 9983000.00
CRVS income_statement (annual, 2022-12-31) — Operating Income: -32565000.00
CRVS income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 46553511.00
CRVS balance_sheet (annual, 2022-12-31) — Other Current Assets: 102000.00
CRVS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 158000.00
CRVS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -563000.00
CRVS income_statement (annual, 2022-12-31) — Other Gand A: 8097000.00
CRVS income_statement (annual, 2022-12-31) — Other Income Expense: -9396000.00
CRVS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 129000.00
CRVS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 587000.00
CRVS balance_sheet (annual, 2022-12-31) — Other Properties: 4890000.00
CRVS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 29144000.00
CRVS balance_sheet (annual, 2022-12-31) — Payables: 1976000.00
CRVS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 8253000.00
CRVS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1113000.00
CRVS balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 626000.00
CRVS income_statement (annual, 2022-12-31) — Pretax Income: -41307000.00
CRVS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRVS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -66191000.00
CRVS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -269000.00
CRVS balance_sheet (annual, 2022-12-31) — Receivables: 633000.00
CRVS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 367000.00
CRVS income_statement (annual, 2022-12-31) — Research And Development: 24468000.00
CRVS balance_sheet (annual, 2022-12-31) — Retained Earnings: -307688000.00
CRVS cash_flow (annual, 2022-12-31) — Sale Of Investment: 43162000.00
CRVS cash_flow (annual, 2022-12-31) — Sale Of PPE: 22000.00
CRVS income_statement (annual, 2022-12-31) — Selling General And Administration: 8097000.00
CRVS balance_sheet (annual, 2022-12-31) — Share Issued: 46553511.00
CRVS income_statement (annual, 2022-12-31) — Special Income Charges: 22000.00
CRVS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 2692000.00
CRVS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 56115000.00
CRVS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 56115000.00
CRVS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CRVS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CRVS balance_sheet (annual, 2022-12-31) — Total Assets: 68240000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Capitalization: 56115000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Debt: 2601000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 56115000.00
CRVS income_statement (annual, 2022-12-31) — Total Expenses: 32565000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12125000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 24576000.00
CRVS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1373000.00
CRVS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -32565000.00
CRVS income_statement (annual, 2022-12-31) — Total Other Finance Cost: -654000.00
CRVS income_statement (annual, 2022-12-31) — Total Unusual Items: 22000.00
CRVS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 22000.00
CRVS balance_sheet (annual, 2022-12-31) — Working Capital: 32912000.00
CRVS income_statement (annual, 2023-12-31) — +Operating Expense: 23407000.00
CRVS income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Accounts Payable: 1525000.00
CRVS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 26000.00
CRVS balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 37000.00
CRVS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4697000.00
CRVS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 374363000.00
CRVS cash_flow (annual, 2023-12-31) — Amortization Of Securities: -894000.00
CRVS income_statement (annual, 2023-12-31) — Basic Average Shares: 48025274.00
CRVS income_statement (annual, 2023-12-31) — Basic EPS: -0.56
CRVS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13159000.00
CRVS cash_flow (annual, 2023-12-31) — Capital Expenditure: -34000.00
CRVS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 1374000.00
CRVS balance_sheet (annual, 2023-12-31) — Capital Stock: 5000.00
CRVS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 12620000.00
CRVS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 27149000.00
CRVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 7855000.00
CRVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 15541000.00
CRVS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -23935000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Account Payable: -451000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -3578000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1108000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -1227000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Payable: -451000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -4029000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -8000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Receivables: 562000.00
CRVS cash_flow (annual, 2023-12-31) — Change In Working Capital: -3594000.00
CRVS cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 562000.00
CRVS cash_flow (annual, 2023-12-31) — Changes In Cash: -539000.00
CRVS balance_sheet (annual, 2023-12-31) — Common Stock: 5000.00
CRVS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 38684000.00
CRVS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 7843000.00
CRVS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 3041000.00
CRVS balance_sheet (annual, 2023-12-31) — Current Assets: 27956000.00
CRVS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1374000.00
CRVS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1374000.00
CRVS balance_sheet (annual, 2023-12-31) — Current Liabilities: 6869000.00
CRVS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 151000.00
CRVS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 151000.00
CRVS income_statement (annual, 2023-12-31) — Diluted Average Shares: 48025274.00
CRVS income_statement (annual, 2023-12-31) — Diluted EPS: -0.56
CRVS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -27029000.00
CRVS income_statement (annual, 2023-12-31) — EBIT: -23407000.00
CRVS income_statement (annual, 2023-12-31) — EBITDA: -23256000.00
CRVS income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -5284000.00
CRVS cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 5284000.00
CRVS cash_flow (annual, 2023-12-31) — End Cash Position: 12620000.00
CRVS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 7855000.00
CRVS cash_flow (annual, 2023-12-31) — Free Cash Flow: -23969000.00
CRVS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CRVS income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -967000.00
CRVS income_statement (annual, 2023-12-31) — General And Administrative Expense: 6881000.00
CRVS balance_sheet (annual, 2023-12-31) — Gross PPE: 6082000.00
CRVS income_statement (annual, 2023-12-31) — Interest Income: 1584000.00
CRVS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1584000.00
CRVS balance_sheet (annual, 2023-12-31) — Invested Capital: 38684000.00
CRVS cash_flow (annual, 2023-12-31) — Investing Cash Flow: 15541000.00
CRVS balance_sheet (annual, 2023-12-31) — Investments And Advances: 16123000.00
CRVS balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 16123000.00
CRVS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 7843000.00
CRVS balance_sheet (annual, 2023-12-31) — Leases: 2084000.00
CRVS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 16123000.00
CRVS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 171000.00
CRVS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 7843000.00
CRVS income_statement (annual, 2023-12-31) — Net Income: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -27029000.00
CRVS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -27029000.00
CRVS income_statement (annual, 2023-12-31) — Net Interest Income: 1584000.00
CRVS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 15575000.00
CRVS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1584000.00
CRVS balance_sheet (annual, 2023-12-31) — Net PPE: 1385000.00
CRVS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -34000.00
CRVS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 38684000.00
CRVS income_statement (annual, 2023-12-31) — Normalized EBITDA: -23256000.00
CRVS income_statement (annual, 2023-12-31) — Normalized Income: -27029000.00
CRVS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -23935000.00
CRVS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 5284000.00
CRVS income_statement (annual, 2023-12-31) — Operating Income: -23407000.00
CRVS income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49038582.00
CRVS balance_sheet (annual, 2023-12-31) — Other Current Assets: 220000.00
CRVS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 245000.00
CRVS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -967000.00
CRVS income_statement (annual, 2023-12-31) — Other Gand A: 6881000.00
CRVS income_statement (annual, 2023-12-31) — Other Income Expense: -5206000.00
CRVS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 89000.00
CRVS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 78000.00
CRVS balance_sheet (annual, 2023-12-31) — Other Properties: 3827000.00
CRVS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 14529000.00
CRVS balance_sheet (annual, 2023-12-31) — Payables: 1525000.00
CRVS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 4566000.00
CRVS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 684000.00
CRVS balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 524000.00
CRVS income_statement (annual, 2023-12-31) — Pretax Income: -27029000.00
CRVS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 12000.00
CRVS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRVS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -47048000.00
CRVS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -34000.00
CRVS balance_sheet (annual, 2023-12-31) — Receivables: 63000.00
CRVS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 151000.00
CRVS income_statement (annual, 2023-12-31) — Research And Development: 16526000.00
CRVS balance_sheet (annual, 2023-12-31) — Retained Earnings: -334717000.00
CRVS cash_flow (annual, 2023-12-31) — Sale Of Investment: 62623000.00
CRVS cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CRVS income_statement (annual, 2023-12-31) — Selling General And Administration: 6881000.00
CRVS balance_sheet (annual, 2023-12-31) — Share Issued: 49038582.00
CRVS income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CRVS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 2147000.00
CRVS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 38684000.00
CRVS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 38684000.00
CRVS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRVS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Total Assets: 45553000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Capitalization: 38684000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Debt: 1374000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 38684000.00
CRVS income_statement (annual, 2023-12-31) — Total Expenses: 23407000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 6869000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 17597000.00
CRVS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -23407000.00
CRVS income_statement (annual, 2023-12-31) — Total Other Finance Cost: -1584000.00
CRVS income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CRVS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRVS balance_sheet (annual, 2023-12-31) — Working Capital: 21087000.00
CRVS cash_flow (quarterly, 2024-09-30) — Depreciation: 21000.00
CRVS income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: -32846000.00
CRVS income_statement (quarterly, 2024-09-30) — Total Unusual Items: -32846000.00
CRVS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: -32846000.00
CRVS income_statement (annual, 2024-12-31) — +Operating Expense: 27548000.00
CRVS income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CRVS balance_sheet (annual, 2024-12-31) — Accounts Payable: 2582000.00
CRVS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 75000.00
CRVS balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 141000.00
CRVS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4626000.00
CRVS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 430859000.00
CRVS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1141000.00
CRVS income_statement (annual, 2024-12-31) — Basic Average Shares: 60985165.00
CRVS income_statement (annual, 2024-12-31) — Basic EPS: -1.02
CRVS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 12620000.00
CRVS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1122000.00
CRVS balance_sheet (annual, 2024-12-31) — Capital Stock: 7000.00
CRVS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 8740000.00
CRVS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 51964000.00
CRVS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 49028000.00
CRVS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -27484000.00
CRVS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -25424000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Account Payable: 1057000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -245000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -571000.00